Literature DB >> 19490272

Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.

Christian Jons1, Arthur J Moss, Coeli M Lopes, Scott McNitt, Wojciech Zareba, Ilan Goldenberg, Ming Qi, Arthur A M Wilde, Wataru Shimizu, Jorgen K Kanters, Jeffrey A Towbin, Michael J Ackerman, Jennifer L Robinson.   

Abstract

BACKGROUND: Type-1 long-QT syndrome (LQT1) is caused by mutations in the KCNQ1 gene. The purpose of this study was to investigate whether KCNQ1 mutations in highly conserved amino acid residues within the voltage-gated potassium channel family are associated with an increased risk of cardiac events. METHODS AND
RESULTS: The study population involved 492 LQT1 patients with 54 missense mutations in the transmembrane region of the KCNQ1 channel. The amino acid sequences of the transmembrane region of 38 human voltage-gated potassium channels were aligned. An adjusted Shannon entropy score for each amino acid residue was calculated ranging from 0 (no conservation) to 1.0 (full conservation). Cox analysis was used to identify independent factors associated with the first cardiac event (syncope, aborted cardiac arrest, or death). Patients were subcategorized into tertiles by their adjusted Shannon entropy scores. The lowest tertile (score 0-0.469; n = 146) was used as a reference group; patients with intermediate tertile scores (0.470-0.665; n = 150) had no increased risk of cardiac events (HR = 1.19, P = 0.42) or aborted cardiac arrest/sudden cardiac death (HR = 1.58, P = 0.26), and those with the highest tertile scores (>0.665; n = 196) showed significantly increased risk of cardiac events (HR = 3.32, P <0.001) and aborted cardiac arrest/sudden cardiac death (HR = 2.62, P = 0.04). The increased risk in patients with the highest conservation scores was independent of QTc, gender, age, and beta-blocker therapy.
CONCLUSIONS: Mutations in highly conserved amino acid residues in the KCNQ1 gene are associated with a significant risk of cardiac events independent of QTc, gender, and beta-blocker therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490272     DOI: 10.1111/j.1540-8167.2009.01455.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  9 in total

Review 1.  Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy.

Authors:  John R Giudicessi; Michael J Ackerman
Journal:  Nat Rev Cardiol       Date:  2012-01-31       Impact factor: 32.419

2.  Amino acid-level signal-to-noise analysis of incidentally identified variants in genes associated with long QT syndrome during pediatric whole exome sequencing reflects background genetic noise.

Authors:  Andrew P Landstrom; Ernesto Fernandez; Jill A Rosenfeld; Yaping Yang; Andrew L Dailey-Schwartz; Christina Y Miyake; Hugh D Allen; Daniel J Penny; Jeffrey J Kim
Journal:  Heart Rhythm       Date:  2018-03-02       Impact factor: 6.343

Review 3.  Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.

Authors:  David J Tester; Michael J Ackerman
Journal:  Circulation       Date:  2011-03-08       Impact factor: 29.690

Review 4.  Molecular Pathophysiology of Congenital Long QT Syndrome.

Authors:  M S Bohnen; G Peng; S H Robey; C Terrenoire; V Iyer; K J Sampson; R S Kass
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

5.  High-risk long QT syndrome mutations in the Kv7.1 (KCNQ1) pore disrupt the molecular basis for rapid K(+) permeation.

Authors:  Don E Burgess; Daniel C Bartos; Allison R Reloj; Kenneth S Campbell; Jonathan N Johnson; David J Tester; Michael J Ackerman; Véronique Fressart; Isabelle Denjoy; Pascale Guicheney; Arthur J Moss; Seiko Ohno; Minoru Horie; Brian P Delisle
Journal:  Biochemistry       Date:  2012-11-02       Impact factor: 3.162

Review 6.  Genetics of long QT syndrome.

Authors:  David J Tester; Michael J Ackerman
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

Review 7.  Risk stratification in electrical cardiomyopathies.

Authors:  Christian Veltmann; Rainer Schimpf; Martin Borggrefe; Christian Wolpert
Journal:  Herz       Date:  2009-11       Impact factor: 1.443

8.  A novel mutation KCNQ1p.Thr312del is responsible for long QT syndrome type 1.

Authors:  Xiao-Meng Chen; Kai Guo; Hong Li; Qiu-Fen Lu; Chao Yang; Ying Yu; Jian-Wen Hou; Yu-Dong Fei; Jian Sun; Jun Wang; Yi-Xue Li; Yi-Gang Li
Journal:  Heart Vessels       Date:  2018-07-14       Impact factor: 2.037

9.  Phylogenetic and physicochemical analyses enhance the classification of rare nonsynonymous single nucleotide variants in type 1 and 2 long-QT syndrome.

Authors:  John R Giudicessi; Jamie D Kapplinger; David J Tester; Marielle Alders; Benjamin A Salisbury; Arthur A M Wilde; Michael J Ackerman
Journal:  Circ Cardiovasc Genet       Date:  2012-09-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.